Protalix BioTherapeutics, Inc.

AMEX:PLX

Biotechnology

Healthcare
$3.02 +4.21%

+$0.09 today

Market cap
$254.64M
Beta
0.01
P/E (TTM)
11.0
EPS (TTM)
$0.19
52W Low $1.32High $3.19

Volume 0.96M

Average 0.81M

Balance Sheet

Inspect the capital base behind the business.

Assets

$82.35M

FY 2025 · Annual

+12.2% YoY

Liabilities

$34.12M

FY 2025 · Annual

+12.9% YoY

Equity

$48.23M

FY 2025 · Annual

+11.6% YoY

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents38.99M17.11M23.63M19.76M14.68M
Short-term Investments05.07M20.93M15.07M15.59M
Net Receivables3.44M4.59M5.27M2.91M8.84M
Inventory17.95M16.8M19.05M21.24M25.73M
Other Current Assets380K536K611K596K1.44M
Total Current Assets61.67M44.88M69.93M60.08M66.67M
Property, Plant & Equipment (Net)9.92M9.64M10.88M10.02M12.58M
Goodwill00000
Intangible Assets00000
Long-term Investments00000
Tax Assets003.09M2.86M2.52M
Other Non-current Assets2.08M1.27M528K462K578K
Total Non-current Assets12M10.91M14.5M13.34M15.67M
Total Assets73.67M55.79M84.43M73.42M82.35M
Account Payables6.99M5.86M4.32M4.53M5.26M
Short-term Debt0021.66M00
Tax Payables0530K2.88M3.48M0
Deferred Revenue8.55M13.18M000
Other Current Liabilities1.51M11.06M4.94M1.81M2.31M
Total Current Liabilities33.18M32.43M45.53M25.62M26.52M
Long-term Debt27.89M28.19M000
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)11.79M0000
Other Non-current Liabilities2.47M1.64M714K559K661K
Total Non-current Liabilities46.53M34M5.34M4.59M7.6M
Total Liabilities79.7M66.43M50.87M30.21M34.12M
Common Stock46K54K73K76K80K
Retained Earnings(374.93M)(389.86M)(381.55M)(378.39M)(385M)
Accumulated OCI00000
Other Stockholders Equity00000
Minority Interest00000
Total Equity(6.04M)(10.64M)33.57M43.21M48.23M
Total Debt33.47M33.47M27.69M5.53M8.32M
Net Debt(5.52M)16.36M4.06M(14.23M)(6.36M)

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$41.7M
Short-term Investments$10.1M
Receivables$2.9M
Inventory$30.5M
Other Current$1.1M
Total Current Assets$86.4M
PP&E (Net)$12.9M
Tax Assets$2.4M
Other Non-current$589.0K
Total Non-current Assets$16.0M
Total Assets$102.3M

Analysis

Selected assets total $102.3M for Latest. The largest visible component is Cash & Equivalents at $41.7M, about 40.8% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
10-QQuarterly reportNov 10, 2026
8-KCurrent reportNov 10, 2026
SC 13GSC 13G filingOct 15, 2026
4Statement of changes in beneficial ownershipSep 9, 2026
4Statement of changes in beneficial ownershipSep 4, 2026

How much cash does PLX have?

Protalix BioTherapeutics, Inc. (PLX) reported $14.68M in cash and equivalents in fiscal 2025.

How much debt does PLX carry?

Protalix BioTherapeutics, Inc. (PLX) reported $8.32M of total debt, with net debt of -$6.36M.